CJC-1295 + Ipamorelin

$99.99

CJC-1295 + Ipamorelin – Research Peptide Complex
Class: GHRH / Ghrelin mimetic synergistic blend
Form: Lyophilized powder
Purity: ≥ 99% (HPLC verified individual components)
Storage (dry): Room temperature, away from light
Storage (reconstituted): Refrigerate 2–8°C
Solvent compatibility: Bacteriostatic Water (preferred)
CJC-1295 (without DAC) and Ipamorelin is a widely studied research combination that leverages two distinct pathways to stimulate the endogenous release of growth hormone. CJC-1295 + Ipamorelin acts as a Growth Hormone Releasing Hormone (GHRH) analog, while Ipamorelin serves as a selective Growth Hormone Secretagogue (GHS) and ghrelin receptor agonist. This dual-action blend is utilized in laboratory models to investigate hormone secretion patterns and their effects on metabolic regulation.
Key Research Focus Areas
Endogenous Hormone Secretion: Analysis of the synergistic pulse frequency and amplitude of growth hormone in research models.
Metabolic Rate & Lipid Turnover: Investigation of the blend’s influence on adipocyte metabolism and fatty acid oxidation.
Cellular Recovery & Hypertrophy: Study of its impact on muscle protein synthesis and recovery from physical stress simulations.
Sleep Architecture & Circadian Rhythm: Researching how these peptides interact with deep-wave sleep cycles in pre-clinical studies.
Bone Mineral Density Signaling: Evaluation of its role in promoting osteoblast activity and long-term skeletal integrity.
Format Options
10 mg (5mg + 5mg) lyophilized powder
Optional BAC solvent available separately
Important Notice
All products are sold for laboratory research use

CJC-1295 + Ipamorelin

Name: CJC-1295 + Ipamorelin
SKU: 650
Availability: InStock

Research Peptide Blend

CJC-1295 + Ipamorelin is a research peptide blend combining two extensively studied peptides that work through complementary growth hormone pathways. This combination has gained significant interest in preclinical research for its potential effects on growth hormone signaling, tissue regeneration, muscle recovery, and metabolic function.

Potential Research Applications

Current preclinical and investigational research has explored CJC-1295 + Ipamorelin for its potential role in:

Supporting growth hormone and IGF-1 research
Promoting muscle recovery
Supporting tissue regeneration
Investigating body composition
Supporting metabolic function
Promoting exercise recovery
Supporting healthy aging research
Investigating protein synthesis pathways

Mechanism of Action

Although research is ongoing, CJC-1295 + Ipamorelin has demonstrated activity through several biological pathways, including:

Stimulation of growth hormone-releasing hormone (GHRH) receptors
Selective activation of growth hormone secretagogue (GHSR-1a) receptors
Promotion of endogenous growth hormone release
Support of IGF-1 signaling and protein synthesis
Modulation of metabolic and recovery-related pathways

These mechanisms have made CJC-1295 + Ipamorelin a significant area of interest in regenerative medicine and endocrine research.

Product Information

High-purity lyophilized research peptide blend
Manufactured under strict quality standards
Third-party tested for identity and purity
Intended exclusively for laboratory and scientific research applications

Research Disclaimer

This product is intended for laboratory research purposes only. It is not approved by the U.S. Food and Drug Administration (FDA) for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any disease. It should only be handled by qualified professionals in appropriate research settings.